PharmacoLearnIt’s Important to Know!

← Biopharmaceutics and Pharmacokinetics Practicals

Bioavailability from Urinary Excretion Data for Two Drugs

bioavailability urinary excretion
bioavailability urinary excretion

1. Aim

To study year 4 biopharmaceutics 8 using supervised records and report the supported outcome. Actual case, sample, and result must be entered in the student record.

2. Requirements

Approved de-identified dataset or teaching case, current method, source identifiers, calibration and control records where relevant, graphing or calculation tool, supervisor, and privacy or safety procedure. Record the assigned sample and use approved software. Drug identity, dose, and acceptance criteria are to be recorded from the assigned current monograph or approved college method in the student record.

3. Theory

Urinary recovery can inform extent of absorption only when the drug or measured metabolite, collection completeness, renal handling, and comparison design support it. The syllabus says two drugs; a cross-drug ratio is not automatically relative bioavailability. The exact validated relationship must be supplied.

4. Procedure

  1. Confirm the syllabus entry, approved source, ethics or privacy requirements, and method.
  2. Record actual labels, units, time points, controls, and missing information without guessing.
  3. Work through the supervised case or dataset: Check urine collection intervals, analyte, assay, dose, completeness, and the approved model for each drug. Sum recovered amounts and report the comparison only when justified.
  4. Separate raw observations from calculations and check method suitability.
  5. Use verified formulae and local software only if the full dataset and method support them.
  6. State the supported result, limitations, and every missing item as Record here.

5. Observation and calculation

Student record field Entry
Case or product Record here
Method Record here
Observation Record here
Inference Record here
Supervisor check Record here
Outcome Record here

Assumed values or observations for practice only: Assumed recovered amounts are 30 mg and 40 mg for two assumed records. These invented amounts cannot yield bioavailability without dose and excretion-fraction information. All invented inputs and outputs are assumed, not a patient result or laboratory instruction.

6. Output or final result

Provide a labelled urine collection and recovery and supervisor-reviewed conclusion. Record the supervised outcome here.

Teaching-lab safety: Clinical cases must be de-identified and supervised. Human or animal bioavailability work requires prior ethical authorization. No assumed example authorizes dosing or sampling. Software-dependent fitting belongs in the actual lab with its approved program.

This page is a supervised-activity guide; it does not report a completed case.

7. Sources

← Calculate Ka, Ke, Half-Life, Cmax, AUC, AUMC and MRTAUC and Bioequivalence from Given Data for Two Drugs →

Back to Biopharmaceutics and Pharmacokinetics Practicals · All Pharm D Practicals · Pharm D

Theory notes: Pharm D Year 4, 4.5 Biopharmaceutics and Pharmacokinetics